Oveporexton
April 4, 2026
309
12
1
4.21%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Dr John Kruse Episodes Around April 4, 2026
See what was published immediately before and after this episode.
1:42Now PlayingOveporexton
Segments
YouTube Description
as posted by the channelOrexin is a polypeptide neurotransmitter intimately involved in regulating wakefulness and sleep. Belsomra, Dayvigo, and Quviviq are orexin receptor blockers used to treat insomnia, and some of modafinil/Provigil's actions seem to come from activating orexin neurons in the hypothalamus. The most common type of narcolepsy derives from destruction of these orexin neurons, and now Takeda Pharmaceuticals is on the verge of gaining FDA approval of the orexin receptor activator, oveporexton, to treat narcolepsy. Study results indicate that oveporexton increases daytime wakefulness, improves sleep, and decreases other symptoms of narcolepsy. Given the extensive symptom overlap between ADHD and narcolepsy, some day orexin agonists may be used for treating ADHD.
#shorts #health #mentalhealth #adhd #orexin
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.